Discovery and Identification of Small Molecules as Methuosis Inducers with in Vivo Antitumor Activities

J Med Chem. 2018 Jun 28;61(12):5424-5434. doi: 10.1021/acs.jmedchem.8b00753. Epub 2018 Jun 19.

Abstract

Methuosis is a novel nonapoptotic mode of cell death characterized by vacuole accumulation in the cytoplasm. In this article, we describe a series of azaindole-based compounds that cause vacuolization in MDA-MB-231 cells. The most potent vacuole inducer, compound 13 (compound 13), displayed differential cytotoxicities against a broad panel of cancer cell lines, such as MDA-MB-231, A375, HCT116, and MCF-7, but it did not inhibit the growth of the nontumorigenic epithelial cell line MCF-10A. A mechanism study confirmed that the cell death was caused by inducing methuosis. Furthermore, compound 13 exhibited substantial pharmacological efficacy in the suppression of tumor growth in a xenograft mouse model of MDA-MB-231 cells without apparent side effects, which makes this compound the first example of a methuosis inducer with potent in vivo efficacy. These results demonstrate that methuosis inducers might serve as novel therapeutics for the treatment of cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / pharmacology*
  • Cell Death / drug effects
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor / methods
  • Female
  • Half-Life
  • Humans
  • Mice, Inbred BALB C
  • Mice, Inbred ICR
  • Small Molecule Libraries / chemistry
  • Small Molecule Libraries / pharmacology*
  • Vacuoles / drug effects
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • Small Molecule Libraries